These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 39182924)
21. Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative. Calis KA; Archdeacon P; Bain R; DeMets D; Donohue M; Elzarrad MK; Forrest A; McEachern J; Pencina MJ; Perlmutter J; Lewis RJ Clin Trials; 2017 Aug; 14(4):342-348. PubMed ID: 28503947 [TBL] [Abstract][Full Text] [Related]
22. Ensuring the Scientific Value and Feasibility of Clinical Trials: A Qualitative Interview Study. Morrell W; Gelinas L; Zarin D; Bierer BE AJOB Empir Bioeth; 2023; 14(2):99-110. PubMed ID: 36599052 [TBL] [Abstract][Full Text] [Related]
23. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
24. Training the Next Generation of Data Monitoring Committee Members: An Initiative of the Heart Failure Collaboratory. Fleming TR; Wittes J; Fiuzat M; Bristow MR; Rockhold FW; Connor JT; Saville BR; Claggett B; Cavagna I; Abraham WT; Cook TD; Lindenfeld J; O'Connor C; DeMets DL; JACC Heart Fail; 2024 Aug; 12(8):1317-1327. PubMed ID: 38530701 [TBL] [Abstract][Full Text] [Related]
25. A joint industry-sponsored data monitoring committee model for observational, retrospective drug safety studies in the real-world setting. Major-Pedersen A; McCullen MK; Sabol ME; Adetunji O; Massaro J; Neugut AI; Sosa JA; Hollenberg AN Pharmacoepidemiol Drug Saf; 2021 Jan; 30(1):9-16. PubMed ID: 33179845 [TBL] [Abstract][Full Text] [Related]
26. Reporting of data monitoring boards in publications of randomized clinical trials is often deficient: ACTTION systematic review. Gewandter JS; Kitt RA; Hunsinger MR; Poku J; Lozano J; Chaudari J; Evans S; Gross RA; McDermott MP; Rowbotham MC; Turk DC; Dworkin RH J Clin Epidemiol; 2017 Mar; 83():101-107. PubMed ID: 28126598 [TBL] [Abstract][Full Text] [Related]
27. Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study. Sydes MR; Altman DG; Babiker AB; Parmar MK; Spiegelhalter DJ; Clin Trials; 2004 Feb; 1(1):48-59. PubMed ID: 16281462 [TBL] [Abstract][Full Text] [Related]
28. A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trials. Fernandes RM; van der Lee JH; Offringa M BMC Pediatr; 2009 Dec; 9():77. PubMed ID: 20003383 [TBL] [Abstract][Full Text] [Related]
29. Experiences of the Data Monitoring Committee for the RECOVERY trial, a large-scale adaptive platform randomised trial of treatments for patients hospitalised with COVID-19. Sandercock PAG; Darbyshire J; DeMets D; Fowler R; Lalloo DG; Munavvar M; Staplin N; Warris A; Wittes J; Emberson JR Trials; 2022 Oct; 23(1):881. PubMed ID: 36258219 [TBL] [Abstract][Full Text] [Related]
30. Issues in regulatory guidelines for data monitoring committees. DeMets D; Califf R; Dixon D; Ellenberg S; Fleming T; Held P; Julian D; Kaplan R; Levine R; Neaton J; Packer M; Pocock S; Rockhold F; Seto B; Siegel J; Snapinn S; Stump D; Temple R; Whitley R Clin Trials; 2004; 1(2):162-9. PubMed ID: 16281888 [TBL] [Abstract][Full Text] [Related]
31. Who's minding the data? Data Monitoring Committees in clinical cancer trials. Keating P; Cambrosio A Sociol Health Illn; 2009 Apr; 31(3):325-42. PubMed ID: 19055588 [TBL] [Abstract][Full Text] [Related]
32. An Estimate of the Benefit-Cost Impact of the FDA Guidance on Data Monitoring Committees. Seltzer J Ther Innov Regul Sci; 2015 Sep; 49(5):698-705. PubMed ID: 30227033 [TBL] [Abstract][Full Text] [Related]
33. A Practical Guide to Data Monitoring Committees in Adaptive Trials. Sanchez-Kam M; Gallo P; Loewy J; Menon S; Antonijevic Z; Christensen J; Chuang-Stein C; Laage T Ther Innov Regul Sci; 2014 May; 48(3):316-326. PubMed ID: 30235541 [TBL] [Abstract][Full Text] [Related]
34. Enhancing communication among data monitoring committees and institutional review boards. Taylor HA; Chaisson L; Sugarman J Clin Trials; 2008; 5(3):277-82. PubMed ID: 18559418 [TBL] [Abstract][Full Text] [Related]
35. DMC reports in the 21st century: towards better tools for decision-making. Vandemeulebroecke M; Baillie M; Mirshani A; Lesaffre E Trials; 2023 Apr; 24(1):289. PubMed ID: 37085883 [TBL] [Abstract][Full Text] [Related]
36. Training New DMC Members: A Call to Action. Rockhold F; Mahaffey K; DeMets D Ther Innov Regul Sci; 2024 Mar; 58(2):234-235. PubMed ID: 37749420 [TBL] [Abstract][Full Text] [Related]
37. Bringing data monitoring committee charters into the sunlight. DeMets DL; Zarin DA; Rockhold F; Ellenberg SS; Fleming T; Wittes J Clin Trials; 2023 Aug; 20(4):447-451. PubMed ID: 37231737 [TBL] [Abstract][Full Text] [Related]
38. Understanding the functions and operations of data monitoring committees: Survey and focus group findings. Calis KA; Archdeacon P; Bain RP; Forrest A; Perlmutter J; DeMets DL Clin Trials; 2017 Feb; 14(1):59-66. PubMed ID: 27885056 [TBL] [Abstract][Full Text] [Related]
39. The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of bias. Tharmanathan P; Calvert M; Hampton J; Freemantle N BMC Med Res Methodol; 2008 Mar; 8():12. PubMed ID: 18366697 [TBL] [Abstract][Full Text] [Related]
40. Data monitoring committees, interim analysis and early termination in paediatric trials. Fernandes RM; van der Lee JH; Offringa M Acta Paediatr; 2011 Oct; 100(10):1386-92. PubMed ID: 21434998 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]